Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

SpectraCure

0.03 SEK-21.03 %24/8 17:29
Less than 1K followers

SPEC

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-21.03 %
-4.35 %
-52.96 %
-60.30 %
-74.52 %
-75.25 %
-98.05 %
-99.11 %
-93.64 %

SpectraCure operates in the medical technology sector. The company specializes in research and development of medical technology systems used for the treatment of prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internal solid tumors of various types. The largest operations are found in the Nordic market. The company has its headquarters in Lund.

Read more
Market cap
47.61M SEK
Turnover
428.06K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
13/11
2026

Interim report Q3'26

18/2
2027

Annual report '26

27/5
2027

Interim report Q1'27

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-08-21 08:30

SpectraCure AB (publ): publicerar halvårsrapport för 2026

SpectraCure
Press release2026-08-17 15:00

Patent godkänt i Kanada

SpectraCure
Press release2026-08-11 13:45

Styrelseordförande och styrelseledamot deltar i SpectraCures företrädesemission

SpectraCure

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-08-07 08:52

Styrelsen i SpectraCure offentliggör slutgiltigt utfall i bolagets företrädesemission och beslut om emission av units till emissionsgaranter

SpectraCure
Regulatory press release2026-08-04 18:50

Styrelsen i SpectraCure offentliggör preliminärt utfall i bolagets företrädesemission

SpectraCure
Regulatory press release2026-08-03 16:05

SpectraCure utökar garantinivån i pågående företrädesemission till 75 procent genom toppgarantiåtagande

SpectraCure
Regulatory press release2026-07-21 08:30

Styrelsen i SpectraCure offentliggör memorandum inför delvis säkerställd företrädesemission om cirka 34,2 MSEK

SpectraCure
Press release2026-07-16 14:00

SpectraCures VD Johannes Swartling intervjuas inför kommande företrädesemission

SpectraCure
Regulatory press release2026-07-15 15:00

Extra bolagsstämma i SpectraCure AB (publ) den 15 juli 2026

SpectraCure
Press release2026-06-18 12:45

Nyemissioner.se: Nyemissioner.se - Läs om SpectraCure som genomför en företrädesemission om 34,2 MSEK

SpectraCure
Regulatory press release2026-06-12 08:15

KALLELSE TILL EXTRA BOLAGSSTÄMMA I SPECTRACURE AB (PUBL)

SpectraCure
Regulatory press release2026-06-12 08:10

Styrelsen i SpectraCure har beslutat om en företrädesemission om cirka 34,2 MSEK

SpectraCure
Regulatory press release2026-06-01 13:25

SpectraCure tillsätter ny CFO

SpectraCure
Regulatory press release2026-05-27 15:00

Årsstämma i SpectraCure AB (publ) den 27 maj 2026

SpectraCure
Regulatory press release2026-05-27 11:00

SpectraCure AB (publ): Kvartalsrapport för januari – mars 2026

SpectraCure
Press release2026-05-13 08:40

Uppdatering om SpectraCures kliniska studier inom prostatacancer

SpectraCure
Regulatory press release2026-05-05 18:40

SpectraCure publicerar årsredovisning för 2025

SpectraCure
Press release2026-05-05 12:00

SpectraCure ökar sitt ägande i Deep Light Vision genom kvittningsemission

SpectraCure
Regulatory press release2026-04-22 15:35

KALLELSE TILL ÅRSSTÄMMA I SPECTRACURE AB (PUBL)

SpectraCure
Regulatory press release2026-02-27 11:00

SpectraCure AB (publ): Bokslutskommuniké för januari - december 2025

SpectraCure